Global Histone Deacetylase 1 Market Research Report 2024

Report ID: 1969791 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Histone Deacetylase 1 Market Overview
    1.1 Product Overview and Scope of Histone Deacetylase 1
    1.2 Histone Deacetylase 1 Segment by Type
        1.2.1 Global Histone Deacetylase 1 Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 RCY-1305
        1.2.3 HG-3001
        1.2.4 CS-3158
        1.2.5 ACY-957
        1.2.6 ST-3595
        1.2.7 Others
    1.3 Histone Deacetylase 1 Segment by Application
        1.3.1 Global Histone Deacetylase 1 Sales Comparison by Application: (2022-2028)
        1.3.2 Alopecia
        1.3.3 Endometrial Cancer
        1.3.4 Myelofibrosis
        1.3.5 Neurology
        1.3.6 Skin Cancer
        1.3.7 Others
    1.4 Global Histone Deacetylase 1 Market Size Estimates and Forecasts
        1.4.1 Global Histone Deacetylase 1 Revenue 2017-2028
        1.4.2 Global Histone Deacetylase 1 Sales 2017-2028
        1.4.3 Histone Deacetylase 1 Market Size by Region: 2017 Versus 2021 Versus 2028
2 Histone Deacetylase 1 Market Competition by Manufacturers
    2.1 Global Histone Deacetylase 1 Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Histone Deacetylase 1 Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Histone Deacetylase 1 Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Histone Deacetylase 1 Manufacturing Sites, Area Served, Product Type
    2.5 Histone Deacetylase 1 Market Competitive Situation and Trends
        2.5.1 Histone Deacetylase 1 Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Histone Deacetylase 1 Players Market Share by Revenue
        2.5.3 Global Histone Deacetylase 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Histone Deacetylase 1 Retrospective Market Scenario by Region
    3.1 Global Histone Deacetylase 1 Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Histone Deacetylase 1 Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Histone Deacetylase 1 Market Facts & Figures by Country
        3.3.1 North America Histone Deacetylase 1 Sales by Country
        3.3.2 North America Histone Deacetylase 1 Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Histone Deacetylase 1 Market Facts & Figures by Country
        3.4.1 Europe Histone Deacetylase 1 Sales by Country
        3.4.2 Europe Histone Deacetylase 1 Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Histone Deacetylase 1 Market Facts & Figures by Region
        3.5.1 Asia Pacific Histone Deacetylase 1 Sales by Region
        3.5.2 Asia Pacific Histone Deacetylase 1 Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Histone Deacetylase 1 Market Facts & Figures by Country
        3.6.1 Latin America Histone Deacetylase 1 Sales by Country
        3.6.2 Latin America Histone Deacetylase 1 Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Histone Deacetylase 1 Market Facts & Figures by Country
        3.7.1 Middle East and Africa Histone Deacetylase 1 Sales by Country
        3.7.2 Middle East and Africa Histone Deacetylase 1 Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Histone Deacetylase 1 Historic Market Analysis by Type
    4.1 Global Histone Deacetylase 1 Sales Market Share by Type (2017-2022)
    4.2 Global Histone Deacetylase 1 Revenue Market Share by Type (2017-2022)
    4.3 Global Histone Deacetylase 1 Price by Type (2017-2022)
5 Global Histone Deacetylase 1 Historic Market Analysis by Application
    5.1 Global Histone Deacetylase 1 Sales Market Share by Application (2017-2022)
    5.2 Global Histone Deacetylase 1 Revenue Market Share by Application (2017-2022)
    5.3 Global Histone Deacetylase 1 Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 4SC AG
        6.1.1 4SC AG Corporation Information
        6.1.2 4SC AG Description and Business Overview
        6.1.3 4SC AG Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 4SC AG Histone Deacetylase 1 Product Portfolio
        6.1.5 4SC AG Recent Developments/Updates
    6.2 Acetylon Pharmaceuticals, Inc.
        6.2.1 Acetylon Pharmaceuticals, Inc. Corporation Information
        6.2.2 Acetylon Pharmaceuticals, Inc. Description and Business Overview
        6.2.3 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio
        6.2.5 Acetylon Pharmaceuticals, Inc. Recent Developments/Updates
    6.3 Chipscreen Biosciences Ltd
        6.3.1 Chipscreen Biosciences Ltd Corporation Information
        6.3.2 Chipscreen Biosciences Ltd Description and Business Overview
        6.3.3 Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Chipscreen Biosciences Ltd Histone Deacetylase 1 Product Portfolio
        6.3.5 Chipscreen Biosciences Ltd Recent Developments/Updates
    6.4 Curis, Inc.
        6.4.1 Curis, Inc. Corporation Information
        6.4.2 Curis, Inc. Description and Business Overview
        6.4.3 Curis, Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Curis, Inc. Histone Deacetylase 1 Product Portfolio
        6.4.5 Curis, Inc. Recent Developments/Updates
    6.5 GlaxoSmithKline Plc
        6.5.1 GlaxoSmithKline Plc Corporation Information
        6.5.2 GlaxoSmithKline Plc Description and Business Overview
        6.5.3 GlaxoSmithKline Plc Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 GlaxoSmithKline Plc Histone Deacetylase 1 Product Portfolio
        6.5.5 GlaxoSmithKline Plc Recent Developments/Updates
    6.6 HitGen LTD
        6.6.1 HitGen LTD Corporation Information
        6.6.2 HitGen LTD Description and Business Overview
        6.6.3 HitGen LTD Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 HitGen LTD Histone Deacetylase 1 Product Portfolio
        6.6.5 HitGen LTD Recent Developments/Updates
    6.7 IRBM Science Park SpA
        6.6.1 IRBM Science Park SpA Corporation Information
        6.6.2 IRBM Science Park SpA Description and Business Overview
        6.6.3 IRBM Science Park SpA Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 IRBM Science Park SpA Histone Deacetylase 1 Product Portfolio
        6.7.5 IRBM Science Park SpA Recent Developments/Updates
    6.8 Italfarmaco S.p.A.
        6.8.1 Italfarmaco S.p.A. Corporation Information
        6.8.2 Italfarmaco S.p.A. Description and Business Overview
        6.8.3 Italfarmaco S.p.A. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Italfarmaco S.p.A. Histone Deacetylase 1 Product Portfolio
        6.8.5 Italfarmaco S.p.A. Recent Developments/Updates
    6.9 MEI Pharma, Inc.
        6.9.1 MEI Pharma, Inc. Corporation Information
        6.9.2 MEI Pharma, Inc. Description and Business Overview
        6.9.3 MEI Pharma, Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 MEI Pharma, Inc. Histone Deacetylase 1 Product Portfolio
        6.9.5 MEI Pharma, Inc. Recent Developments/Updates
    6.10 Merck & Co., Inc.
        6.10.1 Merck & Co., Inc. Corporation Information
        6.10.2 Merck & Co., Inc. Description and Business Overview
        6.10.3 Merck & Co., Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Merck & Co., Inc. Histone Deacetylase 1 Product Portfolio
        6.10.5 Merck & Co., Inc. Recent Developments/Updates
    6.11 Mirati Therapeutics Inc.
        6.11.1 Mirati Therapeutics Inc. Corporation Information
        6.11.2 Mirati Therapeutics Inc. Histone Deacetylase 1 Description and Business Overview
        6.11.3 Mirati Therapeutics Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Mirati Therapeutics Inc. Histone Deacetylase 1 Product Portfolio
        6.11.5 Mirati Therapeutics Inc. Recent Developments/Updates
    6.12 Oncolys BioPharma Inc.
        6.12.1 Oncolys BioPharma Inc. Corporation Information
        6.12.2 Oncolys BioPharma Inc. Histone Deacetylase 1 Description and Business Overview
        6.12.3 Oncolys BioPharma Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Oncolys BioPharma Inc. Histone Deacetylase 1 Product Portfolio
        6.12.5 Oncolys BioPharma Inc. Recent Developments/Updates
    6.13 Sigma-Tau S.p.A.
        6.13.1 Sigma-Tau S.p.A. Corporation Information
        6.13.2 Sigma-Tau S.p.A. Histone Deacetylase 1 Description and Business Overview
        6.13.3 Sigma-Tau S.p.A. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Sigma-Tau S.p.A. Histone Deacetylase 1 Product Portfolio
        6.13.5 Sigma-Tau S.p.A. Recent Developments/Updates
    6.14 Syndax Pharmaceuticals, Inc.
        6.14.1 Syndax Pharmaceuticals, Inc. Corporation Information
        6.14.2 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Description and Business Overview
        6.14.3 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio
        6.14.5 Syndax Pharmaceuticals, Inc. Recent Developments/Updates
    6.15 TetraLogic Pharmaceuticals
        6.15.1 TetraLogic Pharmaceuticals Corporation Information
        6.15.2 TetraLogic Pharmaceuticals Histone Deacetylase 1 Description and Business Overview
        6.15.3 TetraLogic Pharmaceuticals Histone Deacetylase 1 Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 TetraLogic Pharmaceuticals Histone Deacetylase 1 Product Portfolio
        6.15.5 TetraLogic Pharmaceuticals Recent Developments/Updates
7 Histone Deacetylase 1 Manufacturing Cost Analysis
    7.1 Histone Deacetylase 1 Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Histone Deacetylase 1
    7.4 Histone Deacetylase 1 Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Histone Deacetylase 1 Distributors List
    8.3 Histone Deacetylase 1 Customers
9 Histone Deacetylase 1 Market Dynamics
    9.1 Histone Deacetylase 1 Industry Trends
    9.2 Histone Deacetylase 1 Market Drivers
    9.3 Histone Deacetylase 1 Market Challenges
    9.4 Histone Deacetylase 1 Market Restraints
10 Global Market Forecast
    10.1 Histone Deacetylase 1 Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Histone Deacetylase 1 by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Histone Deacetylase 1 by Type (2023-2028)
    10.2 Histone Deacetylase 1 Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Histone Deacetylase 1 by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Histone Deacetylase 1 by Application (2023-2028)
    10.3 Histone Deacetylase 1 Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Histone Deacetylase 1 by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Histone Deacetylase 1 by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Histone Deacetylase 1 Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Histone Deacetylase 1 Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Histone Deacetylase 1 Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Histone Deacetylase 1 Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Histone Deacetylase 1 Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Histone Deacetylase 1 Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Histone Deacetylase 1 Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Histone Deacetylase 1 Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Histone Deacetylase 1 Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Histone Deacetylase 1 Manufacturing Sites and Area Served
    Table 11. Manufacturers Histone Deacetylase 1 Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Histone Deacetylase 1 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Histone Deacetylase 1 as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Histone Deacetylase 1 Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Histone Deacetylase 1 Sales Market Share by Region (2017-2022)
    Table 17. Global Histone Deacetylase 1 Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Histone Deacetylase 1 Revenue Market Share by Region (2017-2022)
    Table 19. North America Histone Deacetylase 1 Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Histone Deacetylase 1 Sales Market Share by Country (2017-2022)
    Table 21. North America Histone Deacetylase 1 Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Histone Deacetylase 1 Revenue Market Share by Country (2017-2022)
    Table 23. Europe Histone Deacetylase 1 Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Histone Deacetylase 1 Sales Market Share by Country (2017-2022)
    Table 25. Europe Histone Deacetylase 1 Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Histone Deacetylase 1 Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Histone Deacetylase 1 Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Histone Deacetylase 1 Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Histone Deacetylase 1 Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Histone Deacetylase 1 Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Histone Deacetylase 1 Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Histone Deacetylase 1 Sales Market Share by Country (2017-2022)
    Table 33. Latin America Histone Deacetylase 1 Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Histone Deacetylase 1 Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Histone Deacetylase 1 Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Histone Deacetylase 1 Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Histone Deacetylase 1 Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Histone Deacetylase 1 Revenue Market Share by Country (2017-2022)
    Table 39. Global Histone Deacetylase 1 Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Histone Deacetylase 1 Sales Market Share by Type (2017-2022)
    Table 41. Global Histone Deacetylase 1 Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Histone Deacetylase 1 Revenue Share by Type (2017-2022)
    Table 43. Global Histone Deacetylase 1 Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Histone Deacetylase 1 Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Histone Deacetylase 1 Sales Market Share by Application (2017-2022)
    Table 46. Global Histone Deacetylase 1 Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Histone Deacetylase 1 Revenue Share by Application (2017-2022)
    Table 48. Global Histone Deacetylase 1 Price by Application (2017-2022) & (USD/Pcs)
    Table 49. 4SC AG Corporation Information
    Table 50. 4SC AG Description and Business Overview
    Table 51. 4SC AG Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. 4SC AG Histone Deacetylase 1 Product
    Table 53. 4SC AG Recent Developments/Updates
    Table 54. Acetylon Pharmaceuticals, Inc. Corporation Information
    Table 55. Acetylon Pharmaceuticals, Inc. Description and Business Overview
    Table 56. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Product
    Table 58. Acetylon Pharmaceuticals, Inc. Recent Developments/Updates
    Table 59. Chipscreen Biosciences Ltd Corporation Information
    Table 60. Chipscreen Biosciences Ltd Description and Business Overview
    Table 61. Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Chipscreen Biosciences Ltd Histone Deacetylase 1 Product
    Table 63. Chipscreen Biosciences Ltd Recent Developments/Updates
    Table 64. Curis, Inc. Corporation Information
    Table 65. Curis, Inc. Description and Business Overview
    Table 66. Curis, Inc. Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Curis, Inc. Histone Deacetylase 1 Product
    Table 68. Curis, Inc. Recent Developments/Updates
    Table 69. GlaxoSmithKline Plc Corporation Information
    Table 70. GlaxoSmithKline Plc Description and Business Overview
    Table 71. GlaxoSmithKline Plc Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. GlaxoSmithKline Plc Histone Deacetylase 1 Product
    Table 73. GlaxoSmithKline Plc Recent Developments/Updates
    Table 74. HitGen LTD Corporation Information
    Table 75. HitGen LTD Description and Business Overview
    Table 76. HitGen LTD Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. HitGen LTD Histone Deacetylase 1 Product
    Table 78. HitGen LTD Recent Developments/Updates
    Table 79. IRBM Science Park SpA Corporation Information
    Table 80. IRBM Science Park SpA Description and Business Overview
    Table 81. IRBM Science Park SpA Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 82. IRBM Science Park SpA Histone Deacetylase 1 Product
    Table 83. IRBM Science Park SpA Recent Developments/Updates
    Table 84. Italfarmaco S.p.A. Corporation Information
    Table 85. Italfarmaco S.p.A. Description and Business Overview
    Table 86. Italfarmaco S.p.A. Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 87. Italfarmaco S.p.A. Histone Deacetylase 1 Product
    Table 88. Italfarmaco S.p.A. Recent Developments/Updates
    Table 89. MEI Pharma, Inc. Corporation Information
    Table 90. MEI Pharma, Inc. Description and Business Overview
    Table 91. MEI Pharma, Inc. Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 92. MEI Pharma, Inc. Histone Deacetylase 1 Product
    Table 93. MEI Pharma, Inc. Recent Developments/Updates
    Table 94. Merck & Co., Inc. Corporation Information
    Table 95. Merck & Co., Inc. Description and Business Overview
    Table 96. Merck & Co., Inc. Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 97. Merck & Co., Inc. Histone Deacetylase 1 Product
    Table 98. Merck & Co., Inc. Recent Developments/Updates
    Table 99. Mirati Therapeutics Inc. Corporation Information
    Table 100. Mirati Therapeutics Inc. Description and Business Overview
    Table 101. Mirati Therapeutics Inc. Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 102. Mirati Therapeutics Inc. Histone Deacetylase 1 Product
    Table 103. Mirati Therapeutics Inc. Recent Developments/Updates
    Table 104. Oncolys BioPharma Inc. Corporation Information
    Table 105. Oncolys BioPharma Inc. Description and Business Overview
    Table 106. Oncolys BioPharma Inc. Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 107. Oncolys BioPharma Inc. Histone Deacetylase 1 Product
    Table 108. Oncolys BioPharma Inc. Recent Developments/Updates
    Table 109. Sigma-Tau S.p.A. Corporation Information
    Table 110. Sigma-Tau S.p.A. Description and Business Overview
    Table 111. Sigma-Tau S.p.A. Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 112. Sigma-Tau S.p.A. Histone Deacetylase 1 Product
    Table 113. Sigma-Tau S.p.A. Recent Developments/Updates
    Table 114. Syndax Pharmaceuticals, Inc. Corporation Information
    Table 115. Syndax Pharmaceuticals, Inc. Description and Business Overview
    Table 116. Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 117. Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Product
    Table 118. Syndax Pharmaceuticals, Inc. Recent Developments/Updates
    Table 119. TetraLogic Pharmaceuticals Corporation Information
    Table 120. TetraLogic Pharmaceuticals Description and Business Overview
    Table 121. TetraLogic Pharmaceuticals Histone Deacetylase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 122. TetraLogic Pharmaceuticals Histone Deacetylase 1 Product
    Table 123. TetraLogic Pharmaceuticals Recent Developments/Updates
    Table 124. Production Base and Market Concentration Rate of Raw Material
    Table 125. Key Suppliers of Raw Materials
    Table 126. Histone Deacetylase 1 Distributors List
    Table 127. Histone Deacetylase 1 Customers List
    Table 128. Histone Deacetylase 1 Market Trends
    Table 129. Histone Deacetylase 1 Market Drivers
    Table 130. Histone Deacetylase 1 Market Challenges
    Table 131. Histone Deacetylase 1 Market Restraints
    Table 132. Global Histone Deacetylase 1 Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 133. Global Histone Deacetylase 1 Sales Market Share Forecast by Type (2023-2028)
    Table 134. Global Histone Deacetylase 1 Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 135. Global Histone Deacetylase 1 Revenue Market Share Forecast by Type (2023-2028)
    Table 136. Global Histone Deacetylase 1 Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 137. Global Histone Deacetylase 1 Sales Market Share Forecast by Application (2023-2028)
    Table 138. Global Histone Deacetylase 1 Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 139. Global Histone Deacetylase 1 Revenue Market Share Forecast by Application (2023-2028)
    Table 140. Global Histone Deacetylase 1 Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 141. Global Histone Deacetylase 1 Sales Market Share Forecast by Region (2023-2028)
    Table 142. Global Histone Deacetylase 1 Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 143. Global Histone Deacetylase 1 Revenue Market Share Forecast by Region (2023-2028)
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Histone Deacetylase 1
    Figure 2. Global Histone Deacetylase 1 Market Share by Type in 2021 & 2028
    Figure 3. RCY-1305 Product Picture
    Figure 4. HG-3001 Product Picture
    Figure 5. CS-3158 Product Picture
    Figure 6. ACY-957 Product Picture
    Figure 7. ST-3595 Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Histone Deacetylase 1 Market Share by Application in 2021 & 2028
    Figure 10. Alopecia
    Figure 11. Endometrial Cancer
    Figure 12. Myelofibrosis
    Figure 13. Neurology
    Figure 14. Skin Cancer
    Figure 15. Others
    Figure 16. Global Histone Deacetylase 1 Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Histone Deacetylase 1 Market Size (2017-2028) & (US$ Million)
    Figure 18. Global Histone Deacetylase 1 Sales (2017-2028) & (K Pcs)
    Figure 19. Histone Deacetylase 1 Sales Share by Manufacturers in 2021
    Figure 20. Global Histone Deacetylase 1 Revenue Share by Manufacturers in 2021
    Figure 21. The Global 5 and 10 Largest Histone Deacetylase 1 Players: Market Share by Revenue in 2021
    Figure 22. Histone Deacetylase 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 23. Global Histone Deacetylase 1 Sales Market Share by Region (2017-2022)
    Figure 24. Global Histone Deacetylase 1 Sales Market Share by Region in 2021
    Figure 25. Global Histone Deacetylase 1 Revenue Market Share by Region (2017-2022)
    Figure 26. Global Histone Deacetylase 1 Revenue Market Share by Region in 2021
    Figure 27. U.S. Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Canada Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Germany Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. France Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. U.K. Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Italy Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Russia Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. China Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Japan Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. South Korea Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. India Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Australia Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Taiwan Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Indonesia Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Thailand Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Malaysia Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Philippines Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Vietnam Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Mexico Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Brazil Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Argentina Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Turkey Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 49. Saudi Arabia Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 50. UAE Histone Deacetylase 1 Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 51. Sales Market Share of Histone Deacetylase 1 by Type (2017-2022)
    Figure 52. Manufacturing Cost Structure of Histone Deacetylase 1
    Figure 53. Manufacturing Process Analysis of Histone Deacetylase 1
    Figure 54. Histone Deacetylase 1 Industrial Chain Analysis
    Figure 55. Channels of Distribution
    Figure 56. Distributors Profiles
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
4SC AG
Acetylon Pharmaceuticals, Inc.
Chipscreen Biosciences Ltd
Curis, Inc.
GlaxoSmithKline Plc
HitGen LTD
IRBM Science Park SpA
Italfarmaco S.p.A.
MEI Pharma, Inc.
Merck & Co., Inc.
Mirati Therapeutics Inc.
Oncolys BioPharma Inc.
Sigma-Tau S.p.A.
Syndax Pharmaceuticals, Inc.
TetraLogic Pharmaceuticals
Frequently Asked Questions
Histone Deacetylase 1 report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Histone Deacetylase 1 report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Histone Deacetylase 1 report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports